Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2019-08-13 16:54:44
Reporting Period:
Accepted Time:
2019-08-13 16:54:44
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
21665 Colgate Palmolive Co CL Perfumes, Cosmetics & Other Toilet Preparations (2844) 131815595
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1197000 T John Cahill C/o Colgate-Palmolive Company
300 Park Avenue
New York NY 10022
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-09 8,000 $40.60 30,326 No 4 M Direct
Common Stock Disposition 2019-08-09 8,000 $71.43 22,326 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-08-09 8,000 $0.00 8,000 $40.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-02-17 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 23,143 Indirect By Trust
  1. Exercise of stock options awarded under the issuer's Non-Employee Director Stock Option Plan.
  2. Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's Non-Employee Director Stock Option Plan.
  3. Weighted average price, as these shares were sold in multiple transactions at prices ranging from $71.37 to $71.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. This amount includes 2,515 shares that were previously reported as directly beneficially owned.
  5. Option became exercisable in one-third increments beginning on the first anniversary of the February 17, 2010 grant date.